Susan Orr
Director/Board Member at OPTHEA LIMITED
Net worth: - $ as of 31/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Megan Baldwin | M | 49 | 16 years | |
| Judith Robertson | F | 64 | 3 years | |
| Anton Clarke Atwell | M | - |
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | 6 years |
| Kester Nahen | M | 53 |
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | 5 years |
| Julia Haller | M | 69 | 3 years | |
| Karen Adams | F | - | 3 years | |
| Lawrence Gozlan | M | 45 | 4 years | |
| Michael Gerometta | M | - | 16 years | |
| Reza Dana | M | - |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | - |
| Marc M. P. de Garidel | M | 66 |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | 4 years |
| Ian Leitch | M | 60 | 13 years | |
| Adrienne Graves | M | 69 |
Retina Global
| - |
| Quinton Oswald | M | - | 2 years | |
| Jeremy Levin | M | 70 | 4 years | |
| John S. Pollack | M | - |
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | 7 years |
| Frédéric Guerard | M | 51 | 1 years | |
| Kenneth Harrison | M | 44 |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | - |
| Anshul Thakral | M | 46 | 1 years | |
| Julie Clark | M | - | - | |
| Annie Lee | F | - | 18 years | |
| Peter F. Lang | M | 52 | 1 years | |
| Bruno Gagnon | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Sistenich | M | 49 | 8 years | |
| Dan Spiegelman | M | 65 | 4 years | |
| Timothy Morris | M | 62 | 1 years | |
| Joel Naor | M | - | 1 years | |
| Shirley Kleinman | F | - |
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 19 | 70.37% |
| United States | 5 | 18.52% |
| Israel | 3 | 11.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Susan Orr
- Personal Network
